Skip to menu Skip to content Skip to footer

2005

Conference Publication

Markers of oxidative stress predict cardiac outcomes in patients with CKD

Wong, J., Coombes, J. S., Trobel, N. A., Hawley, C., Campbell, S., Johnson, D. and Isbel, N. M. (2005). Markers of oxidative stress predict cardiac outcomes in patients with CKD. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3–7 September, 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Markers of oxidative stress predict cardiac outcomes in patients with CKD

2005

Journal Article

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 (3), 271-280. doi: 10.1111/j.1365-2125.2004.02235.x

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

2005

Conference Publication

Does uric acid have a pathogenetic role in hypertension and graft dysfunction in renal transplant recipients?

Hawley, C., Armstrong, K., Johnson, D., Campbell, S. and Isbel, N. (2005). Does uric acid have a pathogenetic role in hypertension and graft dysfunction in renal transplant recipients?. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Does uric acid have a pathogenetic role in hypertension and graft dysfunction in renal transplant recipients?

2005

Conference Publication

The role of JAK tyrosine kinases in renal fibrosis involving oxidative stress

Pat, B., Healy, H., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2005). The role of JAK tyrosine kinases in renal fibrosis involving oxidative stress. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3–7 September 2005. Carlton, VIC: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

The role of JAK tyrosine kinases in renal fibrosis involving oxidative stress

2005

Journal Article

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

Johnson, David Wayne, van Eps, Carolyn, Mudge, David William, Wiggins, Kathryn Joan, Armstrong, Kirsty, Hawley, Carmel Mary, Campbell, Scott Bryan, Isbel, Nicole Maree, Nimmo, Graeme Robert and Gibbs, Harry (2005). Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients. Journal of The American Society of Nephrology, 16 (5), 1456-1462. doi: 10.1681/ASN.2004110997

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

2005

Journal Article

Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants

Pat, Betty, Yang, Tao, Kong, Chuize, Watters, Dianne, Johnson, David W. and Gobe, Glenda (2005). Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants. Kidney International, 67 (3), 931-943. doi: 10.1111/j.1523-1755.2005.00157.x

Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants

2005

Conference Publication

Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients

Armstrong, K., Elliott, A. M., Prins, J., Beller, E., Campbell, Scott B., Hawley, C., Johnson, David W. and Isbel, N. (2005). Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients. 6th American Transplant Congress, Seattle, WA, U.S.A., 21-25 May 2005. Oxford, U.K.: Blackwell Publishing. doi: 10.1111/j.1600-6135.2005.abstracts.x

Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients

2005

Conference Publication

Measurement of insulin resistance is not necessary for the identification of the metabolic syndrome in renal transplant recipients

Armstrong, K., Hiremagalur, B., Campbell, S., Hawley, C., Johnson, D., Prins, J. and Isbel, N. (2005). Measurement of insulin resistance is not necessary for the identification of the metabolic syndrome in renal transplant recipients. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, The Australian Academy of Science, Canberra ACT, Australia, 11 - 13 May, 2005. Basingstoke, U.K.: Nature Publishing Group. doi: 10.1111/j.1440-1711.2005.0000.x

Measurement of insulin resistance is not necessary for the identification of the metabolic syndrome in renal transplant recipients

2005

Book Chapter

Kidney disease

Johnson, David W. and Mathew, Timothy (2005). Kidney disease. Guidelines for preventive activities in general practice. (pp. xx-xx) edited by M. Harris, L. Bailey, C. Bridges-Webb, L. Furler, B. Joyner, J. Litt, J. Smith and Y. Zurynski. Melbourne, Vic.: Royal Australasian College of General Practitioners.

Kidney disease

2004

Journal Article

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

Sturtevant, Joanna M., Hawley, Carmel M., Reiger, Kylie, Johnson, David W., Campbell, Scott B., Burke, John R., Bofinger, Andrew and Isbel, Nicole M. (2004). Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders. Nephrology, 9 (6), 406-413. doi: 10.1111/j.1440-1797.2004.00338.x

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

2004

Journal Article

Medicinal herbal extracts - renal friend or foe? Part two: Herbal extracts with potential renal benefits

Wojcikowski, Ken, Johnson, David W. and Gobe, Glenda (2004). Medicinal herbal extracts - renal friend or foe? Part two: Herbal extracts with potential renal benefits. Nephrology, 9 (6), 400-405. doi: 10.1111/j.1440-1797.2004.00355.x

Medicinal herbal extracts - renal friend or foe? Part two: Herbal extracts with potential renal benefits

2004

Journal Article

Increases in peritoneal small solute transport in the first month of peritoneal dialysis predict technique survival

Wiggins, Katryn J., Blizzard, Sophie, Arndt, Mary, O'Shea, Amanda, Watt, Rhonda, Hamilton, Jan, Cottingham, Sharon, Campbell, Scott B., Isbel, Nicole M. and Johnson, David W. (2004). Increases in peritoneal small solute transport in the first month of peritoneal dialysis predict technique survival. Nephrology, 9 (6), 341-347. doi: 10.1111/j.1440-1797.2004.00325.x

Increases in peritoneal small solute transport in the first month of peritoneal dialysis predict technique survival

2004

Journal Article

Disseminated Pyogenic Mycoplasma pneumoniae Infection in a Renal Transplant Recipient, Detected by Broad‐Range Polymerase Chain Reaction

O’Sullivan, Matthew V. N., Isbel, Nicole M., Johnson, David W., Rencken, Karin, Byrne, Shane, Graham, Mary M. and Playford, E. Geoffrey (2004). Disseminated Pyogenic Mycoplasma pneumoniae Infection in a Renal Transplant Recipient, Detected by Broad‐Range Polymerase Chain Reaction. Clinical Infectious Diseases, 39 (9), E98-E99. doi: 10.1086/425125

Disseminated Pyogenic Mycoplasma pneumoniae Infection in a Renal Transplant Recipient, Detected by Broad‐Range Polymerase Chain Reaction

2004

Journal Article

Response: Iron Therapy in Renal Transplant Recipients

Johnson, David W., Mudge, David W., Atcheson, Bronwyn, Taylor, Paul J., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Nicol, David L. and Pillans, Peter (2004). Response: Iron Therapy in Renal Transplant Recipients. Transplantation, 78 (8), 1240-1240. doi: 10.1097/01.TP.0000137102.92992.5F

Response: Iron Therapy in Renal Transplant Recipients

2004

Journal Article

Medicinal herbal extracts - renal friend or foe? Part one: The toxicities of medicinal herbs

Wojcikowski, Ken, Johnson, David W. and Gobe, Glenda (2004). Medicinal herbal extracts - renal friend or foe? Part one: The toxicities of medicinal herbs. Nephrology, 9 (5), 313-318. doi: 10.1111/j.1440-1797.2004.00310.x

Medicinal herbal extracts - renal friend or foe? Part one: The toxicities of medicinal herbs

2004

Journal Article

Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials

Strippoli, Giovanni F.M., Tong, Allison, Johnson, David, Schena, Francesco P. and Craig, Jonathan C. (2004). Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials. American Journal of Kidney Diseases, 44 (4), 591-603. doi: 10.1053/j.ajkd.2004.05.043

Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials

2004

Journal Article

Coca-Cola and kangaroos (Case report)

Mudge, David W. and Johnson, David W. (2004). Coca-Cola and kangaroos (Case report). Lancet, 364 (9440), 1190-1190. doi: 10.1016/S0140-6736(04)17111-0

Coca-Cola and kangaroos (Case report)

2004

Journal Article

Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient

Mudge, David, Atcheson, Bronwyn, Taylor, Paul, Pillans, Peter and Johnson, David (2004). Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient. Therapeutic Drug Monitoring, 26 (4), 453-455. doi: 10.1097/00007691-200408000-00017

Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient

2004

Journal Article

FK778: A powerful immunosuppressive, but will it really be good for you?

Fawcett, Jonathan and Johnson, David W. (2004). FK778: A powerful immunosuppressive, but will it really be good for you?. Transplantation, 78 (1), 7-8. doi: 10.1097/01.TP.0000132563.08111.88

FK778: A powerful immunosuppressive, but will it really be good for you?

2004

Journal Article

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

Atcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia